HK1205449A1 - Package for solid preparation including 5-hydroxy-1h-imidazole-4- carboxamide or salt or hydrate thereof 5--1h--4- - Google Patents

Package for solid preparation including 5-hydroxy-1h-imidazole-4- carboxamide or salt or hydrate thereof 5--1h--4-

Info

Publication number
HK1205449A1
HK1205449A1 HK15106089.2A HK15106089A HK1205449A1 HK 1205449 A1 HK1205449 A1 HK 1205449A1 HK 15106089 A HK15106089 A HK 15106089A HK 1205449 A1 HK1205449 A1 HK 1205449A1
Authority
HK
Hong Kong
Prior art keywords
carboxamide
imidazole
hydrate
hydroxy
package
Prior art date
Application number
HK15106089.2A
Other languages
English (en)
Chinese (zh)
Inventor
中野駿馬
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of HK1205449A1 publication Critical patent/HK1205449A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
HK15106089.2A 2013-01-15 2015-06-26 Package for solid preparation including 5-hydroxy-1h-imidazole-4- carboxamide or salt or hydrate thereof 5--1h--4- HK1205449A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013004996 2013-01-15
PCT/JP2014/050592 WO2014112531A1 (fr) 2013-01-15 2014-01-15 Emballage pour préparation solide comprenant du 5-hydroxy-1h-imidazole-4-carboxamide ou un sel ou hydrate de celui-ci

Publications (1)

Publication Number Publication Date
HK1205449A1 true HK1205449A1 (en) 2015-12-18

Family

ID=51209620

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106089.2A HK1205449A1 (en) 2013-01-15 2015-06-26 Package for solid preparation including 5-hydroxy-1h-imidazole-4- carboxamide or salt or hydrate thereof 5--1h--4-

Country Status (8)

Country Link
US (2) US9089558B2 (fr)
EP (1) EP2946763A4 (fr)
JP (1) JP5860979B2 (fr)
CN (1) CN104271105B (fr)
BR (1) BR112014026250A2 (fr)
HK (1) HK1205449A1 (fr)
RU (1) RU2642670C2 (fr)
WO (1) WO2014112531A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016079120A (ja) * 2014-10-15 2016-05-16 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 包装により安定性が改善されたオランザピン製剤
US20180104183A1 (en) * 2015-04-07 2018-04-19 Nipro Corporation Oral film preparation
US20170304150A1 (en) * 2016-04-19 2017-10-26 Ascent Pharmaceuticals, Inc. Stable packaging system for moisture and oxygen sensitive pharmaceutical dosage forms

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604802B2 (ja) 1976-09-07 1985-02-06 住友化学工業株式会社 制癌剤
US4181731A (en) * 1976-09-07 1980-01-01 Sumitomo Chemical Company, Limited Novel therapeutic application of 4-carbamoyl-5-hydroxyimidazole
JPS5780328A (en) 1980-11-06 1982-05-19 Sumitomo Chem Co Ltd Preparation of stable pharmaceutical preparation
EP0051962B1 (fr) * 1980-11-05 1988-08-24 Sumitomo Chemical Company, Limited Composition pharmaceutique contenant du 4-carbamoyl-imidazolium-5-olate
JPS5835115A (ja) * 1981-08-28 1983-03-01 Sumitomo Chem Co Ltd 長期安定な医薬用製剤の製法
JPS5936624A (ja) 1982-08-23 1984-02-28 Sumitomo Chem Co Ltd 固形製剤の安定化法
JPS60185727A (ja) * 1984-03-05 1985-09-21 Sumitomo Chem Co Ltd ４−カルバモイルイミダゾリウム−５−オレ−ト製剤の安定化法
EP1243524A3 (fr) * 2001-03-16 2004-04-07 Pfizer Products Inc. Trousse pharmaceutique pour médicaments sensibles a l'oxygène
US20060076536A1 (en) * 2004-09-29 2006-04-13 Barshied Scott R Oxygen scavenging pharmaceutical package and methods for making same
BRPI0720248A2 (pt) * 2006-12-07 2013-12-31 Lilly Co Eli Artigo de fabricação de prasugrel
JP5266010B2 (ja) * 2007-09-14 2013-08-21 富士フイルム株式会社 ４−カルバモイル−５−ヒドロキシ−イミダゾール誘導体のスルホン酸塩化合物
ATE539769T1 (de) 2008-03-04 2012-01-15 Lupin Ltd Stabile pharmazeutische zusammensetzungen mit carvedilol
US20110240511A1 (en) * 2008-12-10 2011-10-06 Merck Sharp & Dohme Corp. Packaging for oxygen-sensitive pharmaceutical products
CN102471531A (zh) * 2009-08-17 2012-05-23 巴斯夫欧洲公司 非离子表面活性剂在提高官能化聚烯烃膜的氧清除剂活性中的用途
US9332782B2 (en) * 2010-05-12 2016-05-10 Multisorb Technologies, Inc. Controlled release of water to an oxygen scavenger

Also Published As

Publication number Publication date
EP2946763A4 (fr) 2016-07-27
BR112014026250A2 (pt) 2017-06-27
CN104271105B (zh) 2018-09-28
WO2014112531A1 (fr) 2014-07-24
CN104271105A (zh) 2015-01-07
US20150291535A1 (en) 2015-10-15
US9089558B2 (en) 2015-07-28
RU2014143977A (ru) 2016-05-27
US9481652B2 (en) 2016-11-01
RU2642670C2 (ru) 2018-01-25
JP5860979B2 (ja) 2016-02-16
US20150051408A1 (en) 2015-02-19
EP2946763A1 (fr) 2015-11-25
JPWO2014112531A1 (ja) 2017-01-19

Similar Documents

Publication Publication Date Title
IL273276A (en) salt crystals
HK1224226A1 (zh) 與間水楊酸形成的烟鹼鹽
HK1210155A1 (en) Nitrogen-containing heterocylic compound or salt thereof
GB201322602D0 (en) Pharmaceutical compounds
HK1226347A1 (zh) Aramchol鹽
GB201306610D0 (en) Pharmaceutical compounds
ZA201506296B (en) 2-acylaminothiazole derivative or salt thereof
ZA201602047B (en) Pharmaceutical compounds
IL281072B (en) Processes for the preparation of pyrimidinylcyclopentane compounds
HK1205449A1 (en) Package for solid preparation including 5-hydroxy-1h-imidazole-4- carboxamide or salt or hydrate thereof 5--1h--4-
GB201312386D0 (en) Pharmaceutical compounds
IL245452B (en) Salts of Armachol
GB201317166D0 (en) Pharmaceutical compounds
GB201316780D0 (en) Pharmaceutical compounds
GB201316791D0 (en) Pharmaceutical Compounds
GB201302219D0 (en) Contraceptive compounds
GB201315734D0 (en) Pharmaceutical compounds
GB201315733D0 (en) Pharmaceutical compounds
GB201312464D0 (en) Pharmaceutical compounds
GB201308040D0 (en) System for the transport of molten salt
GB201308781D0 (en) Pharmaceutical compounds
GB201308780D0 (en) Pharmaceutical compounds
GB201308782D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230118